Mattias Neyt
ME-TA, Medical Evaluation & Technology Assessment
3 papers found
Refreshing results…
First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis
Download from doi.orgMissing publications? Search for publications with a matching author name.